Aim To determine frequency and type of thyroid cancer (TC) as well as gender and age distribution of patients operated at the Department of Ear, Nose and Throat (ENT), Cantonal Hospital Zenica, Bosnia and Herzegovina. Methods A retrospective analysis of data obtained from an operating protocol and disease history of patients operated in the eightyear period (2007- 2014) was made according to the frequency and type of thyroid cancer, as well as age and gender of the patients. χ2 test was used for statistical with p˂0.05. Results A total of 818 surgeries of the thyroid gland were conducted, in 714 (87.29%) female and 104 (12.71%) male patients. Malignancies were diagnosed in 74 (9.05%) patients, of whom 64 (86.49%) were females and 10 (13.51%) were males, resulting in the gender prevalence of 8.96% and 9.62%, respectively. The most often presented type was papillary carcinoma, in 48 (out of 74, 64.86%) patients, followed by follicular carcinoma in 10 (13.51%), medullary carcinoma in four (5.41%), Hurthle cell carcinoma in four (5.41%) patients, while anaplastic carcinoma was found in one (1.35%) patient. The number of diagnosed malignancy varied from 0% (in 2007) to 13.91% (in 2014) (p=0.05). Conclusion The prevalence of thyroid cancer is low, but has an increasing trend. A large number of unnecessary surgeries on thyroid gland was performed. Preoperative diagnostic procedures for diseases of the thyroid gland in Cantonal Hospital Zenica should be improved in order to avoid unessential surgeries.
Salkić A, Brkić F, Cickusić A, Cickusić E, Altumbabić H. Thyroid cancer in Tuzla region of Bosnia and Herzegovina: a 10-year study. Coll Antropol. 1999. p. 53–7.
2.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics. 2008. p. 71–96.
3.
Members of the Guideline Development Group. Diagnosis and management of metastatic malignant disease of unknown primary origin. NICE. 2010. p. 4–6.
4.
Yeung M, Serpell J. Management of the solitary thyroid nodule. Oncologist. 2008. p. 105–12.
5.
Layfield L. Fine-needle aspiration in the diagnosis of head and neck lesions: a review and discussion of problems in differential diagnosis. Diagn Cytopathol. 2007. p. 798–805.
6.
Hundahl S, Fleming I, Fremgen A, Menck H. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer. 1998. p. 2638–48.
7.
Jossart G, Clark O. Well-differentiated thyroid cancer. Curr Probl Surg. 1994. p. 933–1012.
8.
Brennan M, Bergstralh E, Van Heerden J, Mcconahey W. Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc. 1991. p. 11–22.
9.
Nel C, Van Heerden J, Goellner J, Gharib H, Mcconahey W, Taylor W, et al. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases. Mayo Clin Proc. 1985. p. 51–8.
10.
Jakubović A, Čičkušić. Ultrazvučna dijagnostika u bolestima štitne žlijezde. Princom; 2015.
11.
Giuffrida D, Gharib H. Controversies in the management of cold, hot, and occult thyroid nodules. Am J Med. 1995. p. 642–50.
12.
Mazzaferri E. Management of a solitary thyroid nodule. N Engl J Med. 1993. p. 553–9.
13.
Hrnčić N, Ramaš A, Altumbabić H, Hodžić Ð, Hatibović H, Šehanović E, et al. Papillary thyroid carcinoma in a female patient with squamous cell carcinoma of the larynx. Med Glas (Zenica). 2014. p. 241–3.
14.
Meurisse M, Claeys N, Paesmans M, Dang N, Degauque M, Delmelle C, et al. Belgian registry of thyroid cancer. Preliminary epidemiological characteristics revealed by a retrospective study (1988-1995). Belgian Thyroid Cancer Study Group. Ann Endocrinol (Paris). 1997. p. 163–71.
15.
Scheiden R, Keipes M, Bock C, Dippel W, Kieffer N, Capesius C. Thyroid cancer in Luxembourg: a national population-based data report. BMC Cancer. 1983. p. 102.
16.
Zivaljevic V, Paunovic I, Diklic A, Krgovic K, Kalezic N, Kazic M, et al. Acta Chir Belg. 2008. p. 328–32.
17.
Trimboli P, Ulisse S, Graziano F, Marzullo A, Ruggieri M, Calvanese A, et al. Trend in thyroid carcinoma size, age at diagnosis, and histology in a retrospective study of 500 cases diagnosed over 20 years. Thyroid. 2006. p. 1151–5.
18.
Šimunović D, Cvjetko I, Gladić V, Elez M, Glasnović M, Leniček T, et al. Possible effects of the 1990-1995 war in Croatia on thyroid cancer epidemiology. Acta Clin Croat. 2000. p. 155–60.
19.
Leonard N, Melcher D. To operate or not to operate? The value of fine needle aspiration cytology in the assessment of thyroid swellings. J Clin Pathol. 1997. p. 941–3.
20.
Miseikyte-Kaubriene E, Ulys A, Trakymas M. The frequency of malignant disease in cytological group of suspected cancer (ultrasound-guided fine-needle aspiration biopsy of non palpable thyroid nodules). 2008. p. 189–94.
21.
Mikosch P, Gallowitsch H, Kresnik E, Jester J, Würtz F, Kerschbaumer K, et al. Value of ultrasound-guided fine-needle aspiration biopsy of thyroid nodules in an endemic goitrearea. Eur J Nucl Med. 2000. p. 62–9.
22.
Gandolfi P, Frisina A, Raffa M, Renda F, Rocchetti O, Ruggeri C, et al. The incidence of thyroid carcinoma in multinodular goiter: retrospective analysis. Acta Biomed. 2004. p. 114–7.
23.
Pezzolla A, Lattarulo S, Milella M, Barile G, Pascazio B, Ciampolillo A, et al. Incidental carcinoma in thyroid pathology: our experience and review of the literature. Ann ItalChir. 2010. p. 165–9.
24.
Slijepcevic N, Zivaljevic V, Marinkovic J, Sipetic S, Diklic A, Paunovic I. Retrospective evaluation of the incidental finding of 403 papillary thyroid microcarcinomas in 2466 patients undergoing thyroid surgery for presumed benign thyroid disease. BMC Cancer. 2015. p. 330.
25.
Pelizzo M, Rubello D, Berbardi C, Gemo G, Bertazza L, Schievano E, et al. Thyroid surgical practices shaping thyroid cancer incidence in North-Eastern Italy. Biomed Pharmacother. 2014. p. 39–43.
26.
Carlini M, Giovannini C, Mercadante E, Castaldi F, Dell´avanzato R, Zazza S. Incidental thyroid microcarcinoma in benign thyroid disease. Incidence in a total of 100 consecutive thyroidectomies. Chir Ital. 2006. p. 441–7.
27.
Sission J. Medical treatment of benign and malignant thyroid tumors. Endocrinol Metab Clin N Am. 1989. p. 359–87.
28.
Učestalost karcinoma štitne žlijezde kod pacijenata operisanih u Kantonalnoj bolnici Zenica u periodu od. 2007.
29.
Hrnčić1 N, Goga1 A, Hrnčić2 S. Marijana Filipovska-Mušanović. Haris Hatibović1;
30.
Kantonalna Z. ORL odjel, 2JU Zavod za medicinu rada i sportsku medicinu Zeničko-dobojskog kantona.
31.
je bio zastupljen papilarni karcinom, u 48 od 74 (64.86%) pacijenta, folikularni karcinom kod 10 (13.51%) pacijenata, a po 4 (5.41%) pacijenta imala su medularni i Hurthle cell karcinom, dok je 1 (1.35%) pacijent imao anaplastični karcinom. Broj dijagnosticiranih karcinoma varirao je od 0%. 2007.
32.
Zaključak Učestalost karcinoma štitne žlijezde je niska, ali ima tendenciju porasta. Napravljen je veliki broj nepotrebnih hirurških zahvata na štitnoj žlijezdi. Preoperativne dijagnostičke procedure za bolesti štitne žlijezde u Kantonalnoj bolnici Zenica trebaju biti poboljšane ako se želi smanjiti broj nepotrebno urađenih operativnih zahvata. Ključne riječi: tireoidektomija, maligna bolest.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
